Mark Capone

Mark Christopher Capone is the founder of Precision Medicine Advisors LLC, founded in 2020, where the title held is Chief Executive Officer.
Current jobs include Independent Director at Mesa Laboratories, Inc. since 2024, Non-Executive Director at Owlstone Medical Ltd., Independent Director at DermTech, Inc. since 2022, Independent Non-Executive Director at Nephrosant, Inc. since 2021, and Independent Director at Sera Prognostics, Inc. starting in 2026.
Former jobs include President, Chief Executive Officer & Director at Myriad Genetics, Inc. from 2015 to 2020, Sales Director & Plant Manager at Eli Lilly & Co., Director at Myriad RBM, Inc., Director at American Clinical Laboratory Association, Non-Executive Director at Microba Life Sciences Ltd., Non-Executive Director at Abcam Ltd. (United Kingdom) from 2021 to 2023, Chief Operating Officer at Myriad Genetic Laboratories, Inc. from 2006 to 2010, and Trustee at Pioneer Theatre Co. Education includes undergraduate and graduate degrees from Massachusetts Institute of Technology conferred in 1991, and an undergraduate degree from The Pennsylvania State University conferred in 1984.